Role of PARP in TNBC: Mechanism of Inhibition, Clinical Applications, and Resistance
Triple-negative breast cancer is a combative cancer type with a highly inflated histological grade that leads to poor theragnostic value. Gene, protein, and receptor-specific targets have shown effective clinical outcomes in patients with TNBC. Cells are frequently exposed to DNA-damaging agents. DN...
Guardado en:
Autores principales: | Desh Deepak Singh, Amna Parveen, Dharmendra Kumar Yadav |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/108999712fb24e77aa9273b0efcdafe2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
PARP Inhibitors in Combination with Radiotherapy: To Do or Not to Do?
por: Amelia Barcellini, et al.
Publicado: (2021) -
PARP Inhibitors: An Innovative Approach to the Treatment of Inflammation and Metabolic Disorders in Sepsis
por: Wasyluk W, et al.
Publicado: (2021) -
Temporal dynamics of base excision/single-strand break repair protein complex assembly/disassembly are modulated by the PARP/NAD+/SIRT6 axis
por: Christopher A. Koczor, et al.
Publicado: (2021) -
Mechanisms of Nucleosome Reorganization by PARP1
por: Natalya V. Maluchenko, et al.
Publicado: (2021) -
Role of poly (ADP-ribose) polymerase-1 and cytokines in acute renal injury in elderly Chinese patients with diabetes mellitus
por: Cao L, et al.
Publicado: (2017)